BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2844551)

  • 1. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1988 Jul; 151(2):205-21. PubMed ID: 2844551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M
    Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U; Fuder H; Moser U; Bümert HG; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):1-10. PubMed ID: 8139696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of muscarinic M2 and M3, but not of M1 and M4 receptors in vagally stimulated contractions of rabbit bronchus/trachea.
    Eltze M; Galvan M
    Pulm Pharmacol; 1994 Apr; 7(2):109-20. PubMed ID: 8081071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferens.
    Matsuno K; Mita S
    Life Sci; 1992; 50(11):799-806. PubMed ID: 1740963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens.
    Lee CM
    Br J Pharmacol; 1985 Nov; 86(3):671-6. PubMed ID: 2998523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M
    Eur J Pharmacol; 1990 May; 180(1):161-8. PubMed ID: 2365000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
    Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney.
    Eltze M; Ullrich B; Mutschler E; Moser U; Bungardt E; Friebe T; Gubitz C; Tacke R; Lambrecht G
    Eur J Pharmacol; 1993 Jul; 238(2-3):343-55. PubMed ID: 8405103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
    Choo LK; Mitchelson F
    Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):601-11. PubMed ID: 1703935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle.
    Gross J; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):505-16. PubMed ID: 9349639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta.
    Jaiswal N; Lambrecht G; Mutschler E; Tacke R; Malik KU
    J Pharmacol Exp Ther; 1991 Sep; 258(3):842-50. PubMed ID: 1716312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
    Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
    Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus.
    Dörje F; Friebe T; Tacke R; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):284-9. PubMed ID: 2280796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
    Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
    Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice.
    Trendelenburg AU; Gomeza J; Klebroff W; Zhou H; Wess J
    Br J Pharmacol; 2003 Feb; 138(3):469-80. PubMed ID: 12569072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.